Your SlideShare is downloading. ×
0
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Market Research Report :Coronary stents market in india 2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Market Research Report :Coronary stents market in india 2013

1,542

Published on

For the complete report, get in touch with us at : info@netscribes.com …

For the complete report, get in touch with us at : info@netscribes.com

Abstract:
Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.

Table of Contents:

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,542
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
72
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Insert Cover Image using Slide Master View Do not distort Coronary Stents Market – India October 2013
  • 2. Executive Summary Market  Coronary stents market in India is expected to grow at a CAGR of x1%% over 2011 - 2017e  There are three types of coronary stents available in the market, bare metal stents (BMS), drugeluting stents (DES), and bioabsorbable stents Drivers: Drivers & Challenges Government Involvement Competitive Landscape Buyer Details      Challenges: Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures  Problems associated with usage  Constant need for innovation and new product development  Regulatory Bodies  Regulatory Policies  Regulatory Processes Major Foreign Companies Major Domestic Companies Company 1 Company 3 Company 5 Company 2 Company 4 Company 6 Top Hospitals Buying Coronary Stents in India Hospital 1 Hospital 3 Hospital 5 Hospital 2 Hospital 4 Hospital 6 CORONARY STENTS MARKET IN INDIA 2013.PPT 2
  • 3. •Economic Indicators •Introduction •Market Overview •Drivers & Challenges •Government Involvement Regulatory Bodies Regulatory Policies Regulatory Processes •Competitive Landscape •Buyer Details •Recent Developments •Strategic Recommendations •Appendix CORONARY STENTS MARKET IN INDIA 2013.PPT 3
  • 4. Economic Indicators (1/3) GDP at Factor Cost: Quarterly INR tn 14 a1 b1 12 c1 a2 b2 c2 11 d1 b4 c4 b3 d2 13 c3 d4 d3 10 Q2 2009-10 Q1 2010-11 Q4 Q3 2012-13 2011-12 Inflation Rate: Monthly % 1.0 a c 0.8 0.6 b d e Feb 2013 - Mar 2013 Mar 2013 - Apr 2013 0.4 0.2 0.0 Nov 2012 - Dec 2012 Dec 2012 - Jan 2013 Jan 2013 - Feb 2013 SANITARYWARE MARKET IN INDIA 2013.PPT 4
  • 5. Indian market for coronary stents is poised to grow in the coming years with emphasis on drug-eluting stents Coronary Stents Market – Overview • Indian market for coronary stents is expected to show steady growth in coming years, providing strong opportunities to present and potential players to earn high revenues and increase their profits • There are three types of coronary stents available in the market, bare metal stent, drug-eluting stents and bioabsorbable stents • Type ‘Y’ stents experience the highest demand while Type ‘Z’ stents are still at a nascent stage Market Size and Growth (Value-Wise) Type 1 INR bn Type 2 Type 3 h 30 10 0 g x1% c d a b a1% b1% a2% b2% c2% c3% d2% d3% 2011 2012 2013e 2014e c1% d1% f3% f2% 2015e g1% Type 2 h1% v 300 h2% h3% 2016e 2017e u x2% t 400 p q 100 p1% q1% 0 p2% q2% 2011 2012 200 g2% g3% Type 3 600 500 f f1% Type 1 ‘000 40 20 Market Size and Growth (Volume-Wise) CORONARY STENTS MARKET IN INDIA 2013.PPT r r1% r3% r2% 2013e s s1% s2% s3% 2014e t1% t3% t2% 2015e u1% v1% u2% u3% v2% v3% 2016e 2017e 5
  • 6. Prices vary not only across stent types but also depending on whether it is indigenously manufactured or is foreign made Coronary Stents – Price Trends Type of stent Bare Metal Bare Metal Drug-Eluting Drug-Eluting Bioabsorbable Indigenous /Foreign Indigenous Price (INR) Remarks • These are price at which distributors purchase from manufacturers • When hospitals procure stents directly from manufacturers, they can get up to ‘x’% discounts Foreign • Price at which distributors supply the stents to hospitals • Difficult for hospitals to procure directly from manufacturers as these stents are manufactured outside India Indigenous • Price at which distributors purchase from manufacturers • Hospitals can get discounts on these price by purchasing directly from the manufacturer Foreign • Price to the end-user, that is, the patients • Distributors can procure the lower priced, foreign made DES for as little as INR ‘a’ Foreign • Was priced INR ‘u’ when it was launched in Dec 2012 • Presently, Abbott has monopoly on these stents but in future as more companies produce these stents, the price is expected to fall CORONARY STENTS MARKET IN INDIA 2013.PPT 6
  • 7. Drivers & Challenges – Summary Drivers Increasing lifestyle based diseases Challenges Improving health infrastructure Problems associated with usage Changing demographics Constant need for innovation and new product development Increased healthcare spending and insurance coverage Advancements in technology and medical procedures CORONARY STENTS MARKET IN INDIA 2013.PPT 7
  • 8. Regulation of medical devices such as stents are done through different divisions under the MoHFW Organizational Structure Level 1 Level 2 Level 3 Level 4 Level 5 Level 6A Level 7A Level 6B Level 7B Level 7C CORONARY STENTS MARKET IN INDIA 2013.PPT Level 7D 8
  • 9. Although there isn’t any specific legislation governing the entire medical devices industry, certain devices are… Regulatory Bodies (1/2) Regulatory Body A • Regulatory Body A is the main body for the regulation of pharmaceuticals and medical devices in India • Within Regulatory Body A, Entity B is responsible for the regulating pharmaceuticals and medical devices and is advised by Body C and Body D • It is responsible for establishing the safety, efficacy, and quality standards for pharmaceuticals and medical devices • A list of regulated pharmaceuticals and devices, Indian Pharmacopeia, is published and updated by Regulatory Body A • It also appoints notified bodies for conducting conformity assessment procedures including tests for all drug and device applications to ensure that it complies with all standards set by the body • Regulatory Body A is also divided into several zonal offices which conduct the pre-licensing and post-licensing inspections, post-market surveillance, and recalls whenever necessary • Apart from the regulatory functions, Regulatory Body A also offers technical guidance and trains regulatory officials and analysts as well as monitors adverse events • Regulatory Body A also works with the World Health Organization to promote Good Manufacturing Practice (GMP) CORONARY STENTS MARKET IN INDIA 2013.PPT 9
  • 10. Market for coronary stents in India is dominated by products from foreign companies Competition Overview Market Share – Volume-Wise (2012) • MNCs have a dominant share in the coronary stents market in India • Products from MNCs are generally viewed as superior to those manufactured by domestic companies Company 1 Company 5 Company 2 Company 6 Company 3 Others Company 4  As a result of this, there is a higher uptake of products from foreign companies while Indian manufacturers find it difficult to get buyers for their products  Even Company Y which exited the stents business in mid 2011, commanded ‘u’% share of the market in 2012 through its products that were stored as inventory • Company 1, company 2 and Company 3 together account for ~’m’% of the market in terms of volume and ‘n’% of the market in terms of value • Company 1 is the clear leader in the market with ‘a’% share in volume terms, followed by Company 2 a% h% g% f% CORONARY STENTS MARKET IN INDIA 2013.PPT b% d% c% 10
  • 11. Competitive Benchmarking – Private Companies (1/4) Key Ratios of Major Private Companies – Operational Basis (FY 2012) (1/3) Operating Margin % Net Margin 100 50 a2 0 b2 a3 a4 b3 b4 -50 -100 -a1 -b1 Company 1 Company 2 Company 3 Company 4 • Company 4 recorded operating margin of a4%, higher than that of Company 3, Company 2 and company 1 which recorded operating margin of a3%, a2% and –a1% respectively • Net margin was highest for Company 3 at b3%%, followed by Company 4 which recorded a net margin of b4% • Company 1 which recorded a negative net margin of a1% had the lowest net margin amongst its peers CORONARY STENTS MARKET IN INDIA 2013.PPT 11
  • 12. Private: Foreign Company – Company 1 (1/5) Company Information Offices and Centres – India Corporate Address Tel No. Fax No. Website Year of Incorporation Mumbai Products and Services Head Office Products/Services Key People Name Designation Person 1 Director Person 2 Director Person 3 Director CORONARY STENTS MARKET IN INDIA 2013.PPT 12
  • 13. Private: Foreign Company – Company 1 (2/5) Shareholders of the Company as on 27/06/2013 Name No. of Shares held Ownership Structure Foreign Holdings 100.00% CORONARY STENTS MARKET IN INDIA 2013.PPT 13
  • 14. Private: Foreign Company – Company 1 (3/5) Financial Snapshot Total Income Key Ratios Net Profit / Loss Particulars INR bn 30 INR bn a2 b2 25 5 c2 0 20 -5 15 d1 10 -15 c1 5 a1 2009 d2 2010 2011 b1 2008 0 -10 -20 -25 Financial Summary y-o-y change (2011-10) 2011 2010 2009 2008 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) • Company earned a net profit of INR XX mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YY Liquidity Ratios • It reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YY Leverage Ratios • It earned an operating margin of X.X per cent in FY 20XX an increase of X.X percentage points over FY 20YY • The company reported debt to equity ratio of X.XX in FY 20XX, an increase of X.X per cent over FY 20YY Current Ratio Cash Ratio Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved CORONARY STENTS MARKET IN INDIA 2013.PPT Decline 14
  • 15. Private: Foreign Company – Company 1 (4/5) Business Highlights Description News Overview • Company 1 operates in the Segment 1, Segment 2, segment 3 and Segment 4 • It was previously the domestic formulations business of Company Y and was renamed as Company 1 after it was acquired by Company Z in 20-- Manufacturing Facility • It has a formulation facility at City 1, State 1 where a Product A is manufactured • However, coronary stents sold by the company in India are manufactured by various subsidiaries of the parent company, company Z Coronary Stents Products • A number of models of coronary stents from the company are available in India • ‘Model 1’ Carotid Stent System and ‘Model 2’ Coronary Stent marketed by the company are manufactured by Company A, City 2, Country 2 • ‘Model 3’ Coronary Stent System and ‘Model 4’ series are manufactured by Company B, City 3, Country 3 • ‘Model 5’ Stent System is manufactured by Company C in its manufacturing facility at City 4, Country 4 • Everolimus Eluting ‘Model 6’, ‘Model 7’, ‘Model 8’, ‘Model 9’, ‘Model 10’ and ‘Model 11’ are manufactured by Company B • ‘Model 12’ stent system are manufactured by Company D, Country 5 CORONARY STENTS MARKET IN INDIA 2013.PPT 15
  • 16. Private: Foreign Company – Company 1 – SWOT Analysis (5/5) S W O T CORONARY STENTS MARKET IN INDIA 2013.PPT 16
  • 17. Buyer Snapshot: List of Top 10 Buyers of Coronary Stents Top 10 hospitals buying coronary stents in India Hospital Name Hospital Logo Hospital Chain Ownership Type Angioplasty Procedures Per Month Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6 Hospital 7 Hospital 8 Hospital 9 Hospital 10 CORONARY STENTS MARKET IN INDIA 2013.PPT 17
  • 18. Public: Domestic Company – Hospital 1 (1/3) Company Information Head Office and Hospital Network– India Corporate Address Tel No. Fax No. Website Year of Incorporation Products and Services Category Head Office Hospital Network Products/Services Key People Name Designation Person 1 President (Institute Body) Person 2 Dean Person 3 Director Person 4 Medical Superintendent CORONARY STENTS MARKET IN INDIA 2013.PPT 18
  • 19. Public: Domestic Company – Hospital 1 (2/3) Business Highlights Description News Overview • Is a group of ‘m’ hospitals across India • Has ‘p’ teaching departments and centers • Has a total of ‘x’ beds • There are ‘y’ doctors and ‘z’ nurses Facilities • Leader in Therapy 1 • It has India's first and only Therapy A training centre • It is a pioneer of Type A surgeries in India, particularly System 1 for Therapy 2, and System 2 Future Plans • Expansion plans of the hospital chain were recently approved by the Body 1 CORONARY STENTS MARKET IN INDIA 2013.PPT 19
  • 20. Public: Domestic Company – Hospital 1 (3/3) Parameter Hospital Indicators Total cardiac patients per month Angioplasties per month Stent providers Purchase decision factors Stents procurement Contact Details Centralized/ Hospital level HOD/ Technician/ Procurement Procedure/ process involved in procurement Contact details purchase Stent Types Overview of Stent Procurement Process CORONARY STENTS MARKET IN INDIA 2013.PPT 20
  • 21. Thank you for the attention Coronary Stents Market – India report is part of Netscribes’ Healthcare Industry Series. For any queries or customized research requirements, contact us at: Phone: E-Mail: +91 22 4098 7600 info@netscribes.com Follow us on: About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. CORONARY STENTS MARKET IN INDIA 2013.PPT 21

×